Clinical Trials on Bladder Exstrophy in New Zealand
Total 667 results
-
Arrowhead PharmaceuticalsRecruitingFacio-Scapulo-Humeral DystrophyNew Zealand
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
Trans Tasman Radiation Oncology GroupCompletedBladder CancerAustralia, New Zealand
-
Valencia Technologies CorporationCompletedOveractive Bladder | Urge Incontinence | Urinary Urge Incontinence | Incontinence, UrinaryUnited States, New Zealand
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaboratorsCompletedSuperficial Bladder CancerUnited States, Australia, New Zealand, Canada, United Kingdom
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Dyne TherapeuticsRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, France, Netherlands, Italy, Germany, New Zealand
-
National Cancer Institute (NCI)TerminatedStage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Bladder Carcinoma | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Bladder Urothelial Carcinoma | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalCompletedUrinary Incontinence | Fecal Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Nocturia | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedBladder Cancer | Urinary BladderUnited States
-
Medical Enterprises Ltd.TerminatedUrinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder CancerUnited States
-
NYU Langone HealthWithdrawn
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
Taipei Medical University Shuang Ho HospitalCompletedLower Urinary Tract Symptoms | Overactive Bladder SyndromeTaiwan
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
C2i GenomicsFox Chase Cancer Center; Baylor College of Medicine; New York University; The Cleveland... and other collaboratorsTerminated
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
Institute of Cancer Research, United KingdomTrans Tasman Radiation Oncology GroupActive, not recruitingBladder CancerUnited Kingdom, New Zealand, Australia
-
National Cancer Institute (NCI)Rutgers Cancer Institute of New JerseyCompleted
-
Virginia Commonwealth UniversityRadboud University Medical Center; University of California, Los Angeles; University... and other collaboratorsRecruitingMyotonic Dystrophy 1United States, Netherlands, United Kingdom, New Zealand, Germany, Italy, Canada, France
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
NYU Langone HealthSociety of Abdominal RadiologyCompletedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminated
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
En Chu Kong HospitalCompleted
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Manhattan Eye, Ear & Throat HospitalNorthwell HealthWithdrawnPattern Dystrophy of MaculaUnited States
-
Yale UniversityBayerCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminatedBladder CancerUnited States
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Far Eastern Memorial HospitalCompletedOveractive Bladder SyndromeTaiwan
-
Memorial Sloan Kettering Cancer CenterAmgenTerminated
-
University of RochesterAstellas Pharma IncTerminated
-
Columbia UniversityTerminatedGall Bladder DiseaseUnited States
-
Weill Medical College of Cornell UniversityNaturex-DbsCompletedOveractive BladderUnited States
-
Weill Medical College of Cornell UniversityPfizerCompletedBladder Outlet ObstructionUnited States
-
Weill Medical College of Cornell UniversityLaborie Medical Technologies Inc.; Urodynamix TechnologiesCompleted
-
Columbia UniversityCompletedBladder Cancer | ComplicationsUnited States
-
Far Eastern Memorial HospitalCompletedOveractive BladderTaiwan
-
Matthew GalskyNovartisTerminatedBladder Cancer | Solid TumorsUnited States
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)CompletedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States